Cyclophosphamide-based, seven-drug hybrid and low-dose involved field radiation for the treatment of childhood and adolescent Hodgkin disease

被引：0
|
作者：
Nitschke, R [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA
来源：
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2001年 / 23卷 / 06期
关键词：
D O I：
10.1097/00043426-200108000-00009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：368 / 369
页数：2
相关论文
共 26 条
  • [21] Localized childhood Hodgkin's disease: Response adapted treatment by chemotherapy (CT) regimen with VP16, bleomycin, vinblastin and prednisone (VBVP) before low-dose radiation therapy (RT). Results of the study by the French society of pediatric oncology (SFOP).
    LandmanParker, J
    Oberlin, O
    Pacquement, H
    Robert, A
    Coze, C
    Thuret, I
    Bertrand, Y
    Nelken, B
    Behar, C
    Schaison, G
    Leverger, G
    Lemerle, J
    BLOOD, 1996, 88 (10) : 352 - 352
  • [22] Localized childhood Hodgkin's disease: Response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90
    Landman-Parker, J
    Pacquement, H
    Leblanc, T
    Habrand, JL
    Terrier-Lacombe, MJ
    Bertrand, Y
    Perel, Y
    Robert, A
    Coze, C
    Thuret, I
    Donadieu, J
    Schaison, G
    Leverger, G
    Lemerle, J
    Oberlin, O
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) : 1500 - 1507
  • [23] TREATMENT OF ADVANCED HODGKINS-DISEASE (HD) WITH HIGH-DOSE CYCLOPHOSPHAMIDE (CY) TOTAL-BODY IRRADIATION (TBI) WITH OR WITHOUT INVOLVED-FIELD RADIATION (IFR) AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    WOLFF, SN
    PHILLIPS, GL
    FAY, JW
    LAZARUS, HM
    HERZIG, RH
    HERZIG, GP
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 253 - 253
  • [24] COMBINED MODALITY TREATMENT IN OVER 200 CHILDREN WITH HODGKINS-DISEASE - RISK-ADAPTED CHEMOTHERAPY, LOW-DOSE INVOLVED FIELD IRRADIATION AND SELECTIVE SPLENECTOMY - A REPORT OF THE COOPERATIVE THERAPY STUDY DAL-HD-82
    SCHELLONG, G
    BRAMSWIG, J
    LUDWIG, R
    GEREIN, V
    JOBKE, A
    JURGENS, H
    KABISCH, H
    STOLLMANN, B
    WEINEL, P
    GADNER, H
    SCHWARZE, EW
    WANNENMACHER, M
    KLINISCHE PADIATRIE, 1986, 198 (03): : 137 - 146
  • [25] Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: A pediatric oncology group study
    Weiner, MA
    Leventhal, B
    Brecher, ML
    Marcus, RB
    Canter, A
    Gieser, PW
    Ternberg, JL
    Behm, FG
    Wharam, MD
    Chauvenet, AR
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (08) : 2769 - 2779
  • [26] Bulky Hodgkin's disease (S-HD) :: Treatment with an initial 7-drug chemotherapy (CT) delivered over 12 weeks followed by high-dose extended field irradiation (EF-RT), seven-year results of the goelams H90M multicentric randomized trial.
    Andrieu, JM
    Jais, JP
    Escoffre-Barbe, M
    Delwail, V
    Desablens, B
    Kiladjian, JJ
    Hunault, M
    Casassus, P
    Ghandour, C
    Le Prisé, PY
    Lejeune, F
    Simon, M
    Traullé, C
    Colonna, P
    BLOOD, 1999, 94 (10) : 528A - 528A
123